Pramipexol Viatris tablets

Pramipexol Viatris is a pharmaceutical product containing the active ingredient pramipexole, primarily used to treat symptoms of Parkinson's disease and Restless Legs Syndrome. As a generic medication, it is manufactured in various facilities across the globe that meet Viatris's quality standards, commonly across Europe and Asia.

The Viatris brand was formed in 2020 through the merger of Mylan and Pfizer's Upjohn division. While the brand is relatively new, its roots trace back to the United States via its predecessor companies. Today, Viatris Inc. is a massive global healthcare company headquartered in the United States, focused on providing access to high-quality medicines across a wide range of therapeutic areas.